4.7 Article

Alternative Splicing of lncRNAs From SNHG Family Alters snoRNA Expression and Induces Chemoresistance in Hepatoblastoma

Related references

Note: Only part of the references are listed.
Article Gastroenterology & Hepatology

DDX17-regulated alternative splicing that produced an oncogenic isoform of PXN-AS1 to promote HCC metastasis

Hong-Zhong Zhou et al.

Summary: This study found a higher frequency of alternative splicing events in HCC tissues with extrahepatic metastasis compared to metastasis-free tissues. DDX17 and PXN-AS1-IR3 act as important metastatic promoters by modulating MYC signaling, suggesting they may be potential prognostic markers for metastatic HCC.

HEPATOLOGY (2022)

Article Biochemistry & Molecular Biology

Nuclear poly(A) binding protein 1 (PABPN1) mediates zygotic genome activation-dependent maternal mRNA clearance during mouse early embryonic development

Long-Wen Zhao et al.

Summary: This study identified the nuclear poly(A) binding protein 1 (PABPN1) as a crucial factor for maternal mRNA decay and revealed its cytoplasmic function in early embryonic development. Depletion of PABPN1 in mice resulted in developmental arrest and mortality at the preimplantation stage, with a failure to remove maternal mRNAs via the Z-decay pathway. PABPN1-mediated Z-decay plays a key role in major zygotic genome activation and regulates the expression of cell fate-determining factors in mouse preimplantation embryos.

NUCLEIC ACIDS RESEARCH (2022)

Article Biochemistry & Molecular Biology

Transcriptomic Profiling Reveals AKR1C1 and AKR1C3 Mediate Cisplatin Resistance in Signet Ring Cell Gastric Carcinoma via Autophagic Cell Death

Nang Lae Lae Phoo et al.

Summary: The study identified AKR1C1 and 1C3 as key regulators of cisplatin resistance in signet ring cell gastric carcinoma (SRCGC) through modulation of redox-dependent autophagy.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Biochemistry & Molecular Biology

RBM6 splicing factor promotes homologous recombination repair of double-strand breaks and modulates sensitivity to chemotherapeutic drugs

Feras E. Machour et al.

Summary: The RNA-binding protein RBM6 has been identified as a novel regulator of DNA double-strand break repair and its deficiency can lead to increased sensitivity of cancer cells, particularly in breast tumors, to certain treatments. The loss of RBM6 in metastatic breast tumors compared to primary tumors suggests it may serve as a potential therapeutic target for advanced breast cancer.

NUCLEIC ACIDS RESEARCH (2021)

Article Biochemistry & Molecular Biology

AKR1B10 protects against UVC-induced DNA damage in breast cancer cells

Yuanqing Zeng et al.

Summary: AKR1B10 is found to protect cells from UVC-induced DNA damage and is involved in the pathway of DNA double-strand break repair, providing new insights into its role in DNA damage repair and pointing towards a new direction in tumorigenesis and cancer drug resistance.

ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2021)

Editorial Material Genetics & Heredity

Exploring the Alternative Splicing of Long Noncoding RNAs

Muhammad Riaz Khan et al.

Summary: Long noncoding RNA (lncRNA) genes, like protein-coding genes, consist of introns and exons and undergo constitutive and/or alternative splicing after transcription. This review outlines the current understanding of lncRNA splice variants and their functional implications in cell biology.

TRENDS IN GENETICS (2021)

Review Pharmacology & Pharmacy

RNA Dysregulation: An Expanding Source of Cancer Immunotherapy Targets

Yang Pan et al.

Summary: Recent advances in high-throughput technologies and rapid accumulation of multiomic cancer profiling data in public repositories have provided opportunities to systematically characterize RNA dysregulation in cancer and identify antigen targets for immunotherapy. However, important conceptual and technological challenges exist due to the complexity of cancer transcriptomes and proteomes.

TRENDS IN PHARMACOLOGICAL SCIENCES (2021)

Review Oncology

The rediscovery of platinum-based cancer therapy

Sven Rottenberg et al.

Summary: Platinum chemotherapy agents continue to be widely used in cancer treatment, with recent insights into DNA repair mechanisms providing valuable explanations for their success. The understanding of defective DNA repair in many cancers sheds new light on secondary drug resistance mechanisms.

NATURE REVIEWS CANCER (2021)

Article Cell Biology

Long noncoding RNA SNHG12 integrates a DNA-PK-mediated DNA damage response and vascular senescence

Stefan Haemmig et al.

SCIENCE TRANSLATIONAL MEDICINE (2020)

Article Gastroenterology & Hepatology

Epigenetic footprint enables molecular risk stratification of hepatoblastoma with clinical implications

Juan Carrillo-Reixach et al.

JOURNAL OF HEPATOLOGY (2020)

Article Biochemistry & Molecular Biology

Small Nucleolar RNAs Determine Resistance to Doxorubicin in Human Osteosarcoma

Martina Godel et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Medicine, Research & Experimental

Mitochondrial localization of PABPN1 in oculopharyngeal muscular dystrophy

Tsukasa Doki et al.

LABORATORY INVESTIGATION (2019)

Review Oncology

Mechanisms of Anticancer Drug Resistance in Hepatoblastoma

Jose J. G. Marin et al.

CANCERS (2019)

Correction Biochemistry & Molecular Biology

Aberrant splicing in B-cell acute lymphoblastic leukemia (vol 46, pg 11357, 2018)

Kathryn L. Black et al.

NUCLEIC ACIDS RESEARCH (2019)

Article Biochemistry & Molecular Biology

Nuclear poly(A)-binding protein 1 is an ATM target and essential for DNA double-strand break repair

Michal Gavish-Izakson et al.

NUCLEIC ACIDS RESEARCH (2018)

Article Multidisciplinary Sciences

The landscape of genomic alterations across childhood cancers

Susanne N. Groebner et al.

NATURE (2018)

Article Biochemistry & Molecular Biology

Aldo-keto reductase 1B10 protects human colon cells from DNA damage induced by electrophilic carbonyl compounds

Xuyu Zu et al.

MOLECULAR CARCINOGENESIS (2017)

Article Biochemistry & Molecular Biology

Human primary liver cancer-derived organoid cultures for disease modeling and drug screening

Laura Broutier et al.

NATURE MEDICINE (2017)

Article Biochemistry & Molecular Biology

CDK12 regulates alternative last exon mRNA splicing and promotes breast cancer cell invasion

Jerry F. Tien et al.

NUCLEIC ACIDS RESEARCH (2017)

Review Gastroenterology & Hepatology

Unresectable hepatoblastoma: current perspectives

Angela D. Trobaugh-Lotrario et al.

Hepatic Medicine-Evidence and Research (2017)

Article Biochemistry & Molecular Biology

Regulated Intron Retention and Nuclear Pre-mRNA Decay Contribute to PABPN1 Autoregulation

Danny Bergeron et al.

MOLECULAR AND CELLULAR BIOLOGY (2015)

Article Gastroenterology & Hepatology

The genomic landscape of hepatoblastoma and their progenies with HCC-like features

Melanie Eichenmueller et al.

JOURNAL OF HEPATOLOGY (2014)

Review Biochemistry & Molecular Biology

Processing of snoRNAs as a new source of regulatory non-coding RNAs

Marina Falaleeva et al.

BIOESSAYS (2013)

Review Biochemistry & Molecular Biology

PABPN1: molecular function and muscle disease

Ayan Banerjee et al.

FEBS JOURNAL (2013)

Review Multidisciplinary Sciences

Cancer Genome Landscapes

Bert Vogelstein et al.

SCIENCE (2013)

Article Biotechnology & Applied Microbiology

Targeted RNA sequencing reveals the deep complexity of the human transcriptome

Tim R. Mercer et al.

NATURE BIOTECHNOLOGY (2012)

Article Biochemistry & Molecular Biology

Small nucleolar RNA 42 acts as an oncogene in lung tumorigenesis

Y-P Mei et al.

ONCOGENE (2012)

Article Oncology

Are snoRNAs and snoRNA host genes new players in cancer?

Gwyn T. Williams et al.

NATURE REVIEWS CANCER (2012)

Article Biochemistry & Molecular Biology

Implication of snoRNA U50 in human breast cancer

Xue-Yuan Dong et al.

JOURNAL OF GENETICS AND GENOMICS (2009)